These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 20396845)

  • 1. [Analysis of the diabetes mellitus screening program in the Federal District, Mexico].
    Alvear-Galindo MG; Laurell AC
    Cad Saude Publica; 2010 Feb; 26(2):299-310. PubMed ID: 20396845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Colombian diabetes risk score for detecting undiagnosed diabetes and impaired glucose regulation.
    Barengo NC; Tamayo DC; Tono T; Tuomilehto J
    Prim Care Diabetes; 2017 Feb; 11(1):86-93. PubMed ID: 27727004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating a diabetes screening program in older than age 30 rural populations, Hamedan District, Iran.
    Seif Rabiei MA; Moradi A
    Soc Work Public Health; 2013; 28(6):591-5. PubMed ID: 23944169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating FINDRISC as a screening tool for type 2 diabetes among overweight adults in the PREVIEW:NZ cohort.
    Silvestre MP; Jiang Y; Volkova K; Chisholm H; Lee W; Poppitt SD
    Prim Care Diabetes; 2017 Dec; 11(6):561-569. PubMed ID: 28801192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of screening questionnaires and risk scores for undiagnosed diabetes: the KORA Survey 2000.
    Rathmann W; Martin S; Haastert B; Icks A; Holle R; Löwel H; Giani G;
    Arch Intern Med; 2005 Feb; 165(4):436-41. PubMed ID: 15738374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose challenge test screening for prediabetes and early diabetes.
    Jackson SL; Safo SE; Staimez LR; Olson DE; Narayan KMV; Long Q; Lipscomb J; Rhee MK; Wilson PWF; Tomolo AM; Phillips LS
    Diabet Med; 2017 May; 34(5):716-724. PubMed ID: 27727467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Random capillary whole blood glucose test as a screening test for diabetes mellitus in a middle-aged population.
    Qiao Q; Keinänen-Kiukaanniemi S; Rajala U; Uusimäki A; Kivelä SL
    Scand J Clin Lab Invest; 1995 Feb; 55(1):3-8. PubMed ID: 7624734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Economic analysis of a screening program for diabetes mellitus in Brazil].
    Georg AE; Duncan BB; Toscano CM; Schmidt MI; Mengue S; Duarte C; Polanczyk CA;
    Rev Saude Publica; 2005 Jun; 39(3):452-60. PubMed ID: 15997322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Diabetic Retinopathy Screening Tool for Low-Income Adults in Mexico.
    Mendoza-Herrera K; Quezada AD; Pedroza-Tobías A; Hernández-Alcaraz C; Fromow-Guerra J; Barquera S
    Prev Chronic Dis; 2017 Oct; 14():E95. PubMed ID: 29023230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasting plasma glucose in screening for NIDDM in the U.S. and Israel.
    Modan M; Harris MI
    Diabetes Care; 1994 May; 17(5):436-9. PubMed ID: 7741837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of 2 h postprandial capillary and venous glucose as a screening test for abnormal glucose tolerance.
    Bumrerraj S; Kaczorowski J; Kessomboon P; Thinkhamrop B; Rattarasarn C
    Prim Care Diabetes; 2012 Oct; 6(3):207-11. PubMed ID: 22541843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a screening tool using electronic health records for undiagnosed Type 2 diabetes mellitus and impaired fasting glucose detection in the Slovenian population.
    Štiglic G; Kocbek P; Cilar L; Fijačko N; Stožer A; Zaletel J; Sheikh A; Povalej Bržan P
    Diabet Med; 2018 May; 35(5):640-649. PubMed ID: 29460977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validating prediction scales of type 2 diabetes mellitus in Spain: the SPREDIA-2 population-based prospective cohort study protocol.
    Salinero-Fort MÁ; de Burgos-Lunar C; Mostaza Prieto J; Lahoz Rallo C; Abánades-Herranz JC; Gómez-Campelo P; Laguna Cuesta F; Estirado De Cabo E; García Iglesias F; González Alegre T; Fernández Puntero B; Montesano Sánchez L; Vicent López D; Cornejo Del Río V; Fernández García PJ; Sabín Rodríguez C; López López S; Patrón Barandío P;
    BMJ Open; 2015 Jul; 5(7):e007195. PubMed ID: 26220868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance: the IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study.
    Franciosi M; De Berardis G; Rossi MC; Sacco M; Belfiglio M; Pellegrini F; Tognoni G; Valentini M; Nicolucci A
    Diabetes Care; 2005 May; 28(5):1187-94. PubMed ID: 15855587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for diabetes mellitus in adults. The utility of random capillary blood glucose measurements.
    Engelgau MM; Thompson TJ; Smith PJ; Herman WH; Aubert RE; Gunter EW; Wetterhall SF; Sous ES; Ali MA
    Diabetes Care; 1995 Apr; 18(4):463-6. PubMed ID: 7497854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cut-off points of fasting fingertip capillary blood glucose for detecting both undiagnosed diabetes and pre-diabetes].
    Zhang YL; Guo SQ; Ma WB; Wang J; Bai GQ; Yang Q; Ti SF; Ma R; Wei RP; Liu WX; Li Z; Yang L; Liu DW; Li ZH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Oct; 31(10):1174-8. PubMed ID: 21162825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the Finnish Diabetes Risk Score (FINDRISC) questionnaire for undiagnosed type 2 diabetes screening in the Slovenian working population.
    Štiglic G; Fijačko N; Stožer A; Sheikh A; Pajnkihar M
    Diabetes Res Clin Pract; 2016 Oct; 120():194-7. PubMed ID: 27592167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of fasting plasma glucose as screening test for NIDDM in older adults. Rancho Bernardo Study.
    Blunt BA; Barrett-Connor E; Wingard DL
    Diabetes Care; 1991 Nov; 14(11):989-93. PubMed ID: 1797513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk-stratified screening for diabetes in adults: results of the first investigation in Hungary].
    Winkler G; Hidvégi T; Vándorfi G; Jermendy G
    Orv Hetil; 2010 Apr; 151(17):691-6. PubMed ID: 20388612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duration of type 2 diabetes mellitus and systolic blood pressure as determinants of severity of coronary stenosis and adverse events in an asymptomatic diabetic population: PROCEED study.
    Venuraju SM; Lahiri A; Jeevarethinam A; Cohen M; Darko D; Nair D; Rosenthal M; Rakhit RD
    Cardiovasc Diabetol; 2019 Apr; 18(1):51. PubMed ID: 31014330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.